Efinaconazole (Jublia)
Efinaconazole (Jublia) is prescription-only
We review what you can buy over the counter, so nothing carrying it appears here. This page is the reference — what it does, what the evidence supports, and what to raise with a prescriber.
The full efinaconazole (jublia) guide
The reason topical treatments for fungal toenails have historically failed is boring and physical: the nail plate is a dense keratin barrier, and most antifungals stick to keratin so tightly that they never reach the nail bed where the infection actually lives.
Efinaconazole was designed backwards from that problem — an azole engineered to bind keratin weakly, dissolved in a low-surface-tension solution that wicks under the nail. It is the most effective topical available for the indication, which is a real achievement and still a modest outcome.
Where the evidence stands, by concern
Evidence for an ingredient is not one grade — it differs concern by concern. Each row below was researched separately against regulatory approvals, clinical guidelines, and trials our team opened and verified; the band and dots rank how central efinaconazole (jublia) is to treating that concern, from first-line therapy down to supportive care, at treatment-level doses and vehicles. A product's own grade weighs its actual formula.
How it's regulated in the US
FDA does not classify ingredients — it classifies products, by what they are sold to do. The same molecule can be a drug active in one product and a cosmetic ingredient in the next, and only the claim on the label decides which. What follows is a statement about that legal standing, not about whether it works — the evidence question is answered separately above.
Approved drug Efinaconazole is a prescription nail solution, and one of only three topical drugs approved for onychomycosis. Nothing sold over the counter for nail fungus has been through that bar.
- nail fungus FDA-approved 10 percent topical solution
Approved by FDA under a New Drug Application
Permitted label wording “For the topical treatment of onychomycosis of the toenails”
Two phase 3 randomized, double-blind, vehicle-controlled trials published in the Journal of the American Academy of Dermatology in 2013 tested 10% solution applied daily for 48 weeks, with assessment at week 52. Complete cure — a fully clear nail plus negative mycology — reached 15.2% and 17.8% versus 3.3% and 5.5% on vehicle; mycological cure ran far higher, in the region of 54%. Cochrane's 2020 review of topical and device-based treatments for toenail fungal infections rated the evidence high-certainty and placed efinaconazole among the better-performing topicals. The honest summary is that the effect is real, reproducible and modest in absolute terms: roughly one in six people gets a completely clear nail, against a background where oral terbinafine still cures more.
How it works
Fungal cell membranes are held together by ergosterol, the fungal counterpart of cholesterol. Making it requires lanosterol 14α-demethylase, a cytochrome P450 enzyme, and efinaconazole blocks that enzyme. Ergosterol production stops, toxic sterol precursors build up, the membrane loses its integrity and the organism cannot sustain growth. That much it shares with every other azole, including ketoconazole and fluconazole. What separates it is pharmaceutics rather than pharmacology. Keratin is the reason nail infections resist topical therapy: a drug that adsorbs strongly to keratin gets trapped in the nail plate and never arrives at the nail bed in free, active form. Efinaconazole has unusually low keratin affinity, so more of it stays unbound and continues moving. Laboratory comparisons show greater free-drug availability and keratin release than ciclopirox 8% or amorolfine 5%, and better transungual penetration than tavaborole 5% or ciclopirox. The vehicle finishes the job. It is a thin, low-surface-tension alcohol solution rather than a lacquer, so it spreads across the nail surface and creeps into the lateral folds, the hyponychium and the space under the plate — the route to the infected nail bed. No film builds up, which is why no weekly removal step exists, and it is also why the solution is flammable and dries fast.
Key benefits
- Highest complete-cure rate demonstrated among approved topical nail antifungals
- Low keratin binding leaves more free drug to reach the nail bed
- Brush applicator wicks under the nail without filing or debridement
- No weekly lacquer removal step, which helps long-course adherence
- Systemic exposure is minimal, avoiding oral antifungal liver monitoring
- Approved for use from age six upward
Concentration & usage
There is one presentation and it is prescription-only in the US: a 10% topical solution, applied once daily to the affected toenail with the built-in brush, covering the whole nail, the cuticle and lateral folds, and the undersurface at the free edge. The course is 48 weeks with response judged at week 52, and there is no evidence base for stopping early. Nail debridement is not required, which is a genuine practical difference from lacquer-based treatments. Nothing sold over the counter contains efinaconazole — an OTC 'fungal nail solution' at a different strength or in an oil or lacquer base has none of this evidence behind it, no matter how similar the packaging looks.
Who it's for & who should be cautious
Who it's for
It is a sensible choice for mild-to-moderate toenail onychomycosis affecting a limited portion of the nail without matrix involvement, particularly for people who cannot take oral terbinafine because of liver disease, drug interactions or a preference to avoid systemic therapy. It also suits anyone who has tried a lacquer and abandoned it over the weekly removal ritual, since daily brushing is a lower-friction habit to keep up for a year.
Who should be cautious
Anyone who wants this to be quick or certain should recalibrate: even at full adherence, most people finishing a 48-week course do not end up with a completely clear nail. Extensive disease, thickened nails, involvement of the matrix at the base, or several affected nails all push the decision toward oral therapy. Skip it if the diagnosis has never been confirmed — plenty of discoloured, thickened nails are trauma, psoriasis or lichen planus, and none of those respond to an antifungal. Ingrown toenails and application-site dermatitis were the most common adverse events in trials, each in roughly 2% of users. Human pregnancy data are absent, and the solution is flammable, so keep it away from heat and flame until it dries.
Pairs with & conflicts
Myths & facts
Myth: A 17% complete cure rate means the drug barely works.
Reality: The endpoint is severe: a nail with zero visible involvement plus a negative culture and microscopy, in a tissue that takes twelve to eighteen months to grow out. Mycological cure — the fungus gone — ran around 54% in the same trials, and vehicle cure sat near 4%. The gap between those two figures mostly measures how slowly a damaged nail regrows, not how often the fungus survives.
Myth: Any topical antifungal will work on a nail if you use it long enough.
Reality: Creams and sprays formulated for skin are stopped by the nail plate, and time does not fix a penetration problem. The drugs that work in nails are the ones engineered for transungual delivery — low keratin binding, low surface tension, a vehicle that reaches the nail bed. Applying an athlete's foot cream to a toenail for a year mostly treats the surrounding skin.
Myth: You have to file or debride the nail first for it to penetrate.
Reality: Lacquer-based treatments require regular removal and filing because the film builds up, but the efinaconazole trials achieved their results with no debridement at all — the solution's design does the penetrating. Aggressive at-home filing of an already fragile nail risks trauma and secondary infection for no demonstrated gain.
Frequently asked questions
How long does efinaconazole take to clear a fungal toenail?
The approved course is 48 weeks of daily application, with the outcome assessed at week 52 — and that timeline is set by nail growth, not by how fast the drug kills fungus. Expect to see healthy nail emerging at the base months before the discoloured portion has grown out at the tip. Stopping at three months because nothing looks different is the usual way the treatment fails.
Is efinaconazole better than a ciclopirox nail lacquer?
On complete cure it performs better in the trial record, and laboratory work attributes the difference to weaker keratin binding and superior penetration through the nail plate. The lacquer also demands weekly alcohol removal, which many people abandon. Cost and insurance coverage often decide the question in practice, since efinaconazole is expensive.
Do I need this or an oral antifungal pill?
Oral terbinafine still produces higher cure rates and is generally preferred for extensive disease, multiple nails, or involvement at the nail base. Topical efinaconazole is the reasonable route for limited disease, or when liver problems, drug interactions or pregnancy planning make a systemic antifungal unappealing. It is a genuine choice, not a consolation prize.
Can I paint nail polish over efinaconazole?
The trials applied it to bare nails, so that is the condition its results were established under, and polish is a physical barrier over the surface the solution needs to spread across. If cosmetic cover matters to you for an occasion, remove it and resume on bare nails rather than layering the treatment on top of lacquer day after day.
Why is efinaconazole flammable?
The vehicle is largely alcohol, which is what gives the solution its low surface tension and lets it creep under the nail edge instead of beading on top. The label warns to avoid heat, flame and smoking during and immediately after application. Once it has dried the concern is over — the caution applies to the wet minute, not the whole day.